Search details
1.
The therapeutic potential of ketones in cardiometabolic disease: impact on heart and skeletal muscle.
Am J Physiol Cell Physiol
; 326(2): C551-C566, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38193855
2.
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Circulation
; 148(15): 1165-1178, 2023 10 10.
Article
in English
| MEDLINE | ID: mdl-37681311
3.
Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice.
Basic Res Cardiol
; 119(1): 133-150, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38148348
4.
Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada.
BMC Public Health
; 24(1): 859, 2024 Mar 20.
Article
in English
| MEDLINE | ID: mdl-38504198
5.
Perinatal iron restriction is associated with changes in neonatal cardiac function and structure in a sex-dependent manner.
Clin Sci (Lond)
; 137(15): 1115-1130, 2023 08 14.
Article
in English
| MEDLINE | ID: mdl-37463130
6.
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuum.
J Cardiovasc Magn Reson
; 25(1): 55, 2023 10 02.
Article
in English
| MEDLINE | ID: mdl-37779191
7.
Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Int J Mol Sci
; 24(6)2023 Mar 22.
Article
in English
| MEDLINE | ID: mdl-36983040
8.
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects.
J Mol Cell Cardiol
; 167: 17-31, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35331696
9.
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin.
Circulation
; 143(22): 2188-2204, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33832341
10.
Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats.
J Cardiovasc Pharmacol
; 79(6): 833-845, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35266922
11.
Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Can J Psychiatry
; 67(6): 470-480, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34520280
12.
Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study.
Can J Psychiatry
; 67(7): 544-552, 2022 07.
Article
in English
| MEDLINE | ID: mdl-34806435
13.
Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.
Subst Use Misuse
; 57(10): 1633-1641, 2022.
Article
in English
| MEDLINE | ID: mdl-35866679
14.
Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
Am J Physiol Heart Circ Physiol
; 320(1): H432-H446, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-33185110
15.
Reactive Oxygen Species Modulator 1 Plays an Obligate Role in Cardiomyocyte Hypertrophy.
Circ Res
; 134(1): 114-116, 2024 01 05.
Article
in English
| MEDLINE | ID: mdl-38018429
16.
Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.
BMC Cardiovasc Disord
; 21(1): 426, 2021 09 10.
Article
in English
| MEDLINE | ID: mdl-34507536
17.
The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
Arch Toxicol
; 95(1): 1-9, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32852568
18.
Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada.
BMC Public Health
; 21(1): 843, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33933061
19.
Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
Harm Reduct J
; 18(1): 61, 2021 06 08.
Article
in English
| MEDLINE | ID: mdl-34103058
20.
Empagliflozin suppresses inflammation and protects against acute septic renal injury.
Inflammopharmacology
; 29(1): 269-279, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32564182